| QNRX |
Quoin Pharmaceuticals Ltd. |
Ordinary Shares, no par value per share |
9% |
$13,673,537 |
|
1,901,585 |
|
Integrated Core Strategies (US) LLC |
20 Oct 2025 |
| TENX |
Tenax Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
6.9% |
$1,882,272 |
+$480,576 |
313,712 |
+34% |
Integrated Core Strategies (US) LLC |
30 Sep 2025 |
| SRZN |
Surrozen, Inc. |
Common Stock, par value $0.0001 per share |
6.6% |
$7,687,568 |
|
564,847 |
|
Millennium Management LLC |
13 Nov 2025 |
| AMN |
AMN Healthcare Services, Inc. |
Common Stock, par value $0.01 per share |
6.4% |
$47,355,025 |
|
2,446,024 |
|
Millennium Management LLC |
04 Nov 2025 |
|
Harvard Ave Acquisition Corporation |
Class A Ordinary Shares, par value $0.0001 per share |
6.4% |
|
|
950,000 |
|
Millennium Management LLC |
23 Oct 2025 |
| BEBE |
TGE Value Creative Solutions Corp |
Class A Ordinary Shares, par value $0.0001 per share |
6% |
|
|
900,000 |
|
Millennium Management LLC |
19 Dec 2025 |
| ZEPP |
Zepp Health Corporation |
Class A Ordinary Shares, par value $0.0001 per share |
5.8% |
$303,731,622 |
|
6,634,592 |
|
Millennium Management LLC |
05 Nov 2025 |
| KIDS |
OrthoPediatrics Corp. |
Common Stock, par value $0.00025 per share |
5.5% |
$25,768,856 |
|
1,390,656 |
|
Millennium Management LLC |
29 Oct 2025 |
| LIVN |
LivaNova PLC |
Ordinary Shares, par value GBP 1.00 per share |
5.4% |
$155,574,571 |
+$47,408,667 |
2,970,114 |
+44% |
Millennium Management LLC |
30 Sep 2025 |
| SLVM |
Sylvamo Corporation |
Common Stock, par value $1.00 per share |
5.4% |
$88,221,844 |
|
2,148,608 |
|
Millennium Management LLC |
18 Nov 2025 |
| ARDX |
Ardelyx, Inc. |
Common Stock, par value $0.0001 per share |
5.4% |
$76,499,983 |
|
13,121,781 |
|
Millennium Management LLC |
05 Jan 2026 |
| BTAI |
BioXcel Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
5.2% |
$3,485,100 |
|
1,028,053 |
|
Millennium Management LLC |
29 Sep 2025 |
| IBIO |
iBio, Inc. |
Common Stock, par value $0.001 per share |
5.2% |
$2,381,191 |
|
1,235,827 |
|
Millennium Management LLC |
15 Jan 2026 |
| MYGN |
Myriad Genetics, Inc. |
Common Stock, par value $0.01 per share |
5.1% |
$34,330,404 |
-$1,275,278 |
4,748,327 |
-3.6% |
Millennium Management LLC |
30 Sep 2025 |
| CYRX |
Cryoport, Inc. |
Common Stock, par value $0.001 per share |
5.1% |
$22,987,571 |
+$3,140,810 |
2,562,717 |
+16% |
Millennium Management LLC |
24 Sep 2025 |
| FHN |
First Horizon Corporation |
Common Stock, par value $0.625 per share |
5% |
$574,422,854 |
|
25,405,699 |
|
Millennium Management LLC |
16 Oct 2025 |
| SLRN |
ACELYRIN, INC. |
Common Stock, par value $0.00001 per share |
4.7% |
$10,513,116 |
|
4,714,402 |
|
Integrated Core Strategies (US) LLC |
31 Dec 2024 |
| HLXB |
Helix Acquisition Corp. II |
Class A Ordinary Shares, par value $0.0001 per share |
4.7% |
$9,878,734 |
|
897,251 |
|
Millennium Management LLC |
30 Jun 2025 |
| ADPT |
Adaptive Biotechnologies Corporation |
Common Stock, par value $0.0001 per share |
4.3% |
$52,732,273 |
|
6,292,634 |
|
Millennium Management LLC |
31 Dec 2024 |
| PYXS |
Pyxis Oncology, Inc. |
Common Stock, par value $0.001 per share |
4% |
$2,388,556 |
-$645,178 |
2,488,079 |
-21% |
Millennium Management LLC |
31 Mar 2025 |
| CPIX |
Cumberland Pharmaceuticals Inc. |
Common Stock, no par value |
4% |
$1,618,467 |
-$571,171 |
598,634 |
-26% |
Integrated Core Strategies (US) LLC |
30 Sep 2025 |
| ACCD |
Accolade, Inc. |
Common Stock, par value $0.0001 per share |
3.8% |
$21,697,844 |
|
3,090,861 |
|
Millennium Management LLC |
31 Dec 2024 |
| SEE |
Sealed Air Corporation |
Common Stock, par value $0.10 per share |
3.7% |
$181,370,784 |
-$72,119,443 |
5,397,940 |
-28% |
Millennium Management LLC |
11 Nov 2025 |
| CMA |
Comerica Incorporated |
Common Stock, par value $5 per share |
3.6% |
$315,762,635 |
-$279,206,324 |
4,608,328 |
-47% |
Millennium Management LLC |
07 Oct 2025 |
| AMG |
Affiliated Managers Group, Inc. |
Common Stock, par value $0.01 per share |
3.6% |
$242,510,253 |
-$116,590,124 |
1,017,113 |
-32% |
Millennium Management LLC |
30 Sep 2025 |
| LXEO |
Lexeo Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
3.2% |
$15,362,583 |
-$3,470,396 |
2,313,642 |
-18% |
Millennium Management LLC |
30 Sep 2025 |
| GVA |
Granite Construction Incorporated |
Common Stock, par value $0.01 per share |
3% |
$99,561,498 |
|
1,283,009 |
|
Millennium Management LLC |
31 Mar 2025 |
| NKTR |
Nektar Therapeutics |
Common Stock, par value $0.0001 per share |
3% |
$32,489,559 |
-$20,590,346 |
570,994 |
-39% |
Millennium Management LLC |
30 Sep 2025 |
| CMPS |
COMPASS Pathways plc |
American Depositary Shares, each representing one ordinary share, par value of GBP 0.008 per share |
3% |
$7,904,535 |
-$1,823,792 |
2,773,521 |
-19% |
Millennium Management LLC |
31 Mar 2025 |
| UTZ |
Utz Brands, Inc. |
Class A Common Stock, par value $0.0001 per share |
2.9% |
$26,388,721 |
-$20,572,134 |
2,542,217 |
-44% |
Millennium Management LLC |
31 Dec 2025 |
| NEO |
NeoGenomics, Inc. |
Common Stock, par value $0.001 per share |
2.8% |
$27,464,422 |
-$26,082,302 |
3,566,808 |
-49% |
Millennium Management LLC |
30 Jun 2025 |
| RVPH |
Reviva Pharmaceuticals Holdings, Inc. |
Common Stock, par value $0.0001 per share |
2.8% |
$912,148 |
|
3,257,670 |
|
Millennium Management LLC |
31 Dec 2025 |
| UWMC |
UWM Holdings Corporation |
Class A Common Stock, par value $0.0001 per share |
2.5% |
$20,943,689 |
-$32,296,628 |
4,974,748 |
-61% |
Millennium Management LLC |
30 Jun 2025 |
| ENTA |
Enanta Pharmaceuticals, Inc. |
Common Stock, par value $0.01 per share |
2.3% |
$10,572,717 |
-$7,381,290 |
670,428 |
-41% |
Millennium Management LLC |
31 Dec 2025 |
| ANGO |
AngioDynamics, Inc. |
Common Stock, par value $0.01 per share |
2% |
$10,818,316 |
-$16,734,886 |
842,548 |
-61% |
Millennium Management LLC |
31 Dec 2025 |
| ABEO |
Abeona Therapeutics Inc. |
Common Stock, par value $0.01 per share |
1.7% |
$3,539,551 |
|
809,966 |
|
Millennium Management LLC |
31 Mar 2025 |
| MIST |
Milestone Pharmaceuticals Inc. |
Common Shares, no par value |
0.6% |
$248,003 |
|
322,082 |
|
Integrated Core Strategies (US) LLC |
31 Mar 2025 |
| ATXS |
Astria Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
0.4% |
$1,616,895 |
-$19,770,311 |
222,101 |
-92% |
Millennium Management LLC |
14 Oct 2025 |
| ANIP |
ANI Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
0.3% |
$5,976,442 |
-$96,309,614 |
65,245 |
-94% |
Millennium Management LLC |
30 Sep 2025 |
| PHIN |
PHINIA Inc. |
Common Stock, par value $0.01 per share |
0% |
$0 |
|
0 |
|
Integrated Core Strategies (US) LLC |
31 Mar 2025 |
| GLNG |
Golar LNG Limited |
Common Shares, par value $1.00 per share |
0% |
$0 |
-$192,830,730 |
0 |
-100% |
Integrated Core Strategies (US) LLC |
31 Mar 2025 |